BDBM50578177 CHEMBL4865483

SMILES CC#CC(=O)N1CCCC[C@H]1c1nc(c(C(N)=O)n1N)-c1ccc(cc1)C(=O)Nc1cc(ccn1)-c1ccc(F)cc1

InChI Key InChIKey=YHNFAXONRPKPAO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50578177   

TargetTyrosine-protein kinase BTK(Human)
Henan Zhiwei Biomedicine

US Patent
LigandPNGBDBM50578177(CHEMBL4865483 | US12291516, Example 92)
Affinity DataIC50: 14.7nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Henan Zhiwei Biomedicine

US Patent
LigandPNGBDBM50578177(CHEMBL4865483 | US12291516, Example 92)
Affinity DataIC50: 14.7nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Henan Zhiwei Biomedicine

US Patent
LigandPNGBDBM50578177(CHEMBL4865483 | US12291516, Example 92)
Affinity DataIC50: 14.7nMAssay Description:Reagent and Procedure by Reaction Biology Corporation:Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.02%. Brij35, 0.02 mg/ml B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Henan Zhiwei Biomedicine

US Patent
LigandPNGBDBM50578177(CHEMBL4865483 | US12291516, Example 92)
Affinity DataIC50: 14.7nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Henan Zhiwei Biomedicine

US Patent
LigandPNGBDBM50578177(CHEMBL4865483 | US12291516, Example 92)
Affinity DataIC50: 15nMAssay Description:Inhibition of full-length N-terminal GST tagged BTK (2 to 659 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetCytoplasmic tyrosine-protein kinase BMX(Human)
Henan Zhiwei Biomedicine

US Patent
LigandPNGBDBM50578177(CHEMBL4865483 | US12291516, Example 92)
Affinity DataIC50: 154nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2025
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Henan Zhiwei Biomedicine

US Patent
LigandPNGBDBM50578177(CHEMBL4865483 | US12291516, Example 92)
Affinity DataIC50: 1.09E+3nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2025
Entry Details
US Patent

TargetTyrosine-protein kinase ITK/TSK(Human)
Henan Zhiwei Biomedicine

US Patent
LigandPNGBDBM50578177(CHEMBL4865483 | US12291516, Example 92)
Affinity DataIC50: 3.31E+4nMAssay Description:In House Procedure for BTK, BMX, EGFR and ITK. Kinase inhibitory activities of compounds were evaluated using the Enzyme-linked immunosorbent assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2025
Entry Details
US Patent